Received Jun 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | CH929 | — |
patient only received the diluent portion; patient only received the diluent portion; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate dose of vaccine administered in a female patient who received Herpes zoster (Shingrix) solution for injection (batch number CH929 with expiry date 07-JUL-2027) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate dose of vaccine administered (Verbatim: patient only received the diluent portion) and inappropriate preparation of medication (Verbatim: patient only received the diluent portion). The outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were not applicable. Additional Information: GSK Receipt Date: 16-JUN-2026 pharmacist called to inform that a nurse practitioner ordered a Shingrix injection for a patient to be administered by her nurse, and she was telling that when she injected the patient, she did not mix the two vials, so she basically just injected the patient with the adjuvanted suspension and not the actual drug. No further details were provided.